News & Updates
Filter by Specialty:
Infliximab does not contribute to long-term weight gain in IBD patients
20 May 2022
byStephen Padilla
Treatment with infliximab does not lead to a general long-term weight gain in patients with inflammatory bowel disease (IBD), claims a study.
Infliximab does not contribute to long-term weight gain in IBD patients
20 May 2022
Investigational drug gains upper hand over placebo in reducing CDI recurrence rates
20 May 2022
byAudrey Abella
SER-109, an investigational oral microbiome therapeutic, achieves superiority over placebo in reducing recurrent Clostridioides difficile infection (CDI) rates, according to updated findings from the phase III ECOSPOR-III trial.
Investigational drug gains upper hand over placebo in reducing CDI recurrence rates
20 May 2022
Long-term aspirin use lowers HCC risk in chronic HBV patients
14 May 2022
Use of aspirin in the long term appears to markedly reduce the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV), a study has shown.
Long-term aspirin use lowers HCC risk in chronic HBV patients
14 May 2022
Rectal evacuation disorders tied to poor bowel preparation in chronic constipation patients
10 May 2022
Outlet dysfunction is associated with suboptimal bowel preparation and decreased cecal intubation, among others, in patients with chronic constipation undergoing colonoscopy, reveals a study.